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REPORT
Rapid production of a chimeric antibody-antigen fusion protein based on
2A-peptide cleavage and green fluorescent protein expression in CHO cells
Hans Van der Weken , Eric Cox *, and Bert Devriendt *
Laboratory of Immunology, Faculty of Veterinary Medicine, Ughent, Ghent, Belgium
ABSTRACT
To enable large-scale antibody production, the creation of a stable, high producer cell line is essential. This
process often takes longer than 6 months using standard limited dilution techniques and is very labor
intensive. The use of a tri-cistronic vector expressing green fluorescent protein (GFP) and both antibody
chains, separated by a GT2A peptide sequence, allows expression of all proteins under a single promotor in
equimolar ratios. By combining the advantages of 2A peptide cleavage and single cell sorting, a chimeric
antibody-antigen fusion protein that contained the variable domains of mouse IgG with a porcine IgA
constant domain fused to the FedF antigen could be produced in CHO-K1 cells. After transfection, a strong
correlation was found between antibody production and GFP expression (r = 0.69) using image analysis of
formed monolayer patches. This enables the rapid selection of GFP-positive clones using automated image
analysis for the selection of high producer clones. This vector design allowed the rapid selection of high
producer cloneswithin a time-frame of 4weeks after transfection. The highest producing clone had a specific
antibody productivity of 2.32 pg/cell/day. Concentrations of 34 mg/L were obtained using shake-flask batch
culture. The produced recombinant antibody showed stable expression, binding and minimal degradation.
In the future, this antibody will be assessed for its effectiveness as an oral vaccine antigen.
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Introduction
Systemic vaccines often fail to induce an effective mucosal
immune response, characterized by the induction of pathogen-
specific secretory immunoglobulin A (SIgA).1 Oral vaccines are
muchmore effective in achievingmucosal immunity and have the
added benefit of being easy and safe to administer.2 One of the
main drawbacks of oral vaccination is the poor uptake by the
intestinal epithelium and the ensuing delivery to the underlying
gut-associated lymphoid tissue.3 Selective targeting of vaccine
antigens to a transport protein on the intestinal epithelium
might solve this problem.4 Recently, we showed that antibody-
mediated delivery of antigens towards aminopeptidase N (APN),
a membrane receptor expressed on enterocytes and involved in
epithelial transcytosis, triggered systemic and mucosal antibody
responses in a piglet model.5,6 However, in these experiments,
porcine APN-specific rabbit or mouse IgG were used, which
resulted in rabbit or mouse IgG-specific immune responses
upon oral vaccination in piglets. The presence of these antibodies
might affect the efficacy of APN targeting in a prime-boost
vaccination regime. To minimize these responses, a recombinant
porcine APN-specific chimeric mouse-porcine IgA antibody,
linked with a clinically relevant antigen, was designed. By repla-
cing the mouse IgG constant domains with porcine IgA, minimal
immune response and increased antibody stability is expected.7-9
Most recombinant antibodies are produced in Chinese
hamster ovary (CHO) cells due to their capacity for correct
folding, assembly and glycosylation, leading to improved pro-
duction. The creation of a stable, high producer cell line is
essential to support the high demand for antibody
production.10 Antibodies are complex molecules consisting
of both heavy and light chain polypeptides. Moreover, the
ratio of both chains affects the final production of the com-
plete antibody.11,12 Efficient co-expression of the heavy and
light chain is therefore one of the most important aspects in
monoclonal antibody production. This co-expression can gen-
erally be achieved by either co-transfecting two separate vec-
tors, each encoding a single antibody chain, or by transfecting
a single vector encoding both chains.13 Expression on separate
vectors often results in a poor balance of light and heavy chain
expression levels, leading to reduced antibody production.
Multiple studies have shown that expressing both chains
from a single vector significantly improves the expression
ratio.14,15 Co-expression on a single vector can be achieved
by either using two separate promotors, an internal ribosome
entry site (IRES) or “self-cleaving” 2A peptides.16 The use of
an IRES-element often leads to reduced protein expression of
downstream genes, ranging from 6 to 100%, making this
system unpredictable.17-19
Self-cleaving 2A peptides are short, highly conserved sequences
of 18–22 amino acids derived from viruses, such as foot-and-
mouth disease virus (F2A), equine rhinitis A virus (E2A), porcine
teschovirus-1 (P2A) and thosea asigna virus (T2A). They mediate
“cleavage” of polypeptides during translation by steric hindrance,
resulting in ribosomes skipping the formation of a glycyl-propyl
(G-P) peptide bond at the C-terminus of the 2A peptide.20,21 After
successful skipping, the 2A peptide remains bound to the
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upstream protein and often a furin cleavage site is inserted to
remove the remaining peptides. The use of 2A peptide cleavage
mostly leads to higher expression levels compared to IRES-based
expression,13 but can also lead to generation of aggregates due to
incorrect cleavage and folding.16 Efficiency of correct cleavage and
antibody production is highly dependent on the cell line used and
2A peptide sequence. T2A peptide cleavage in addition to a GSG
sequence (GT2A) showed the highest cleavage efficiency and
antibody expression levels in CHO cells.20
Another major bottleneck in the production of recombi-
nant antibodies is the selection of stable transfected cells with
high expression. By using a 2A peptide sequence to link GFP
expression to protein production, the screening time and
effort could be significantly improved. Co-expression of fluor-
ochromes with a protein of interest using 2A peptide
sequences has been done before, but only for localization
purposes and not for screening of antibody production
levels.22 Here, we report on the use of 2A peptide cleavage
for the simultaneous expression of both the heavy and light
antibody chains, in combination with GFP to simplify and
improve the screening of high producer antibody clones.
Results
GFP expression levels correlate with antibody production
levels by CHO cells
A tri-cistronic vector was designed expressing GFP and
a recombinant antibody, separated by furin and a GT2A peptide
sequence (Figure 1). CHO-K1 cells were transfected with this
vector and were selected with G418 to produce stable transfec-
tions. Five days after transfection, clear GFP expression could be
observed in some cells, but with a high variation in intensity
(Figure 2(a)). After 9 days of selection, the 10% highest GFP-
expressing cells were single-cell sorted into 96-well plates and
grown further until colonies formed (Figure 2(b)). In total, from
460 GFPhigh single cells, 50 colonies formed, of which 26 showed
clear GFP expression and formed a monolayer patch. High
variability in colony size, growth kinetics and GFP expression
levels were observed between colonies (Figure 2(c)). Twelve days
after sorting, 23 colonies showed 100% confluency (Figure 2(d))
and were further expanded into a 24-well plate. After 4 days, the
recombinant antibody production level in the supernatant of each
clone was assessed using an anti-porcine IgA sandwich ELISA and
compared to their respective GFP expression using image analysis.
A strong correlation between antibody production and GFP
expression for all 23 selected clones was found using Pearson
correlation (r = 0.55; p = 0.0064) (Figure 2(e)). Colonies not
showing significant antibody production showed either very low
GFP expression or were found to be slow growing cells or colonies
with heterogenous GFP expression levels (Figure 2(c)). Because
the number of developed colonies was very low (10.8%) and half
of them showed no clear GFP expression after colony develop-
ment, a second experiment was performed using 12 days of
selection before single cell sorting. A similar antibody harboring
a single mutation (G99D) in the heavy chain variable domain,
preventing it frombindingAPN,was used. After single cell sorting
the GFPhigh population (Figure 2(b)), 137 colonies were formed
(29.8%), of which 96 (70.1%) showed clear GFP expression and
formed monolayer patches, indicating that a longer selection
procedure improved stable expression of GFP. After collection
of supernatant, a very strong correlation was found between anti-
body production and GFP expression (r = 0.69; p = 5.79 x 10−15)
(Figure 2(f), Left). Colonies not showing significant antibody
production were again found to be slow growing cells or colonies
with low or heterogenous GFP expression. Correlation increased
further (r = 0.78; p = 1.92 x 10−20) 12 days post-sort, when cells
reached 100% confluency (data not shown). Correlation between
antibody production and GFP expression, determined by flow
cytometry instead of image analysis, gave a much higher correla-
tion coefficient (r = 0.86; p = 4.84 x 10−29) (Figure 2(f), Right),
indicating that this method is more precise. The best producing
clone was selected, grown further and adapted to suspension
culture to enable large-scale recombinant antibody production
and purification. Concentrations of 34 mg/L were obtained
using shake-flask batch culture. Both antibody production and
Figure 1. Schematic representation of the vector expressing eGFP and a recombinant antibody consisting of mouse variable domains, porcine IgA constant domains
and the FedF antigen. Furin-GT2A: Furin recognition site, followed by a GSG + T2A-peptide sequence; VL: Mouse variable domain light chain; CL: Porcine constant
domain light chain; VH: Mouse variable domain heavy chain; CH: Porcine constant domain IgA heavy chain; Spacer: (G4S)3-flexible linker; FedF: Tip adhesin of F18
+ enterotoxigenic E. coli; pA: Polyadenylation signal. *: Post-translational cleavage of secretion signal and furin recognition site.
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GFP expression levels remained stable after 4 months of culturing
for the selected clones (Figure 3(a)). GFP expression levels also
remained correlated with antibody production over time
(r = 0.827; p = 0.084) (Figure 3(b)).
Figure 2. (a) Transmission and fluorescence microscopy images of CHO cells 5 days after transfection. (b) Variation in GFP expression levels from stable transfected
cells, 9 and 12 days after transfection (blue and green, respectively), compared to non-transfected cells (red). (c) Variation in GFP expression and growth rate of
developed colonies, 5 days after single cell sorting. (d) Colony development 12 days after single cell sorting. (e) Correlation between antibody production (O.D. in
ELISA) and mean fluorescence intensity (MFI), determined by colony imaging (r = 0.55) for the first transfection. (f) Correlation between antibody production and MFI,
determined by colony imaging (Left; r = 0.69) and flow cytometry (Right; r = 0.86) for the second transfection. Scale bars = 100 µm.
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Purification and quality analysis of the recombinant
antibodies
The produced recombinant antibody was purified by cross-
linking mouse anti-porcine IgA antibodies on a Protein
G column and their stability and functionality were assessed.
The purified antibody was first analyzed with SDS-PAGE and
Western blot (Figure 4). Under reducing conditions, bands
around 25 (light chain) and 75 (heavy chain-FedF) kDa for
the purified αAPN-IgA-FedF (Lane 1) and bands around 25
(light chain) and 50 (heavy chain) kDa for porcine serum IgA
(Lane 2) were revealed. No fusion products composed of light
and heavy chains were observed (100 kDa expected), proving
efficient cleavage of the furin-GT2A peptide sequence. Some
minor degradation (5.3%) of the IgA heavy chain was
observed, resulting in a band around 50 kDa.
Next, the functionality of the purified recombinant antibody
was assessed by flow cytometry and immunohistochemistry. The
purified recombinant antibodies were able to bind to an APN-
expressing epithelial cell line (IPEC-J2-APN) (Figure 5(a)), as
well as to intestinal epithelial cells of the pig ileum (Figure 5(c)).
The fused FedF antigen was also detected after binding to the
IPEC-J2-APN cell line (Figure 5(b)).
Discussion
The fastest and easiest way to produce a stable culture of
antibody-producing cells is by using a mixed population of
transfected cells. Since this results in an undefined and geneti-
cally heterogenous cell population of high and low producer
cells, this is only recommended for the initial screening steps
of the produced antibody. Much higher antibody concentra-
tions can be obtained by generating single cell clones, result-
ing in a defined and homogenous cell system. This process of
screening stable transfected cells for high producer clones via
the traditional limited dilution technique is very time con-
suming and labor intensive and often takes between 6 to
12 months.12,23 Considerable efforts have been made to
improve the selection process of high producer cells.24,25 Co-
transfection with a GFP expressing plasmid is often per-
formed to screen for successful transfections, but this cannot
be directly correlated with antibody production. The use of an
IRES-based approach, where a reporter protein is put under
the same promotor as the expressed antibody allows for better
selection. Approaches based on fluorescence-activated cell
sorting (FACS) using fluorochromes as reporter proteins has
allowed the rapid selection of strong producing clones due to
the correlation between the fluorochrome and antibody
production.26-28 However, in IRES-based expression vectors
the expression of downstream genes is often lower, resulting
in lower yields when producing multimeric proteins, such as
antibodies.18,19 Since it has been shown that an excess of light
compared to heavy chain results in higher production and
reduced aggregation, this could also be considered an advan-
tage for antibody production.14
To express all subunits in equimolar ratios, 2A peptide
cleavage can be used, allowing even the use of tri- and quad-
cistronic vectors.29 The much shorter length of the 2A peptides
(54–66 bp), compared to the IRES-sequence (500–600 bp), can
be an advantage, especially when working with viral transfer
Figure 3. Stability study of GFP expression levels and antibody production over a period of 4 months, showing (a) stable GFP expression and antibody production
over time and (b) correlation between GFP expression and antibody production over time.
Figure 4. SDS-PAGE and Western blot of purified recombinant antibody (Lane 1:
IgA-FedF) or porcine serum IgA (Lane 2) under reducing conditions. AB: Precision
Plus Protein All Blue Standard, LC: Light chain, HC: Porcine IgA heavy chain, HC-
FedF: porcine IgA heavy chain, linked to FedF.
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vectors with a limited packaging capacity. One major drawback
of 2A peptides compared to IRES is that inefficient cleavage
results in the formation of fusion proteins and aggregates. This
cleavage efficiency is highly dependent on the chosen cell line
and the 2A peptide sequence, and can be improved by addition
of a GSG sequence upstream of the 2A peptide. For our vector
design, the GT2A sequence was chosen based on previous
experiments performed by Chng et al. showing efficient clea-
vage and low (<10%) aggregate formation in CHO cells.20
In our approach, as depicted in Figure 6, the advantages of
single cell sorting were combined with 2A peptide cleavage by
placing the genes encoding both antibody chains and GFP
under a single promotor, separated by a GT2A sequence. This
vector design allowed the rapid selection of high producer
clones for production of a chimeric antibody-antigen fusion
protein. Within a time-frame of 4 weeks, a high producing
clone with a specific antibody productivity of 2.32 pg/cell/day
(pcd) had been selected. After adaptation of cells to suspen-
sion growth, production values of 34 mg/L could be obtained
in a shake flask batch culture system. Since we are expressing
a chimeric antibody-antigen fusion protein, lower expression
compared to a regular antibody was expected, since protein
folding might not be optimal. Therefore, it is difficult to
compare specific productivity of selected clones with other
Figure 5. Binding analysis of purified antibody on the APN-expressing epithelial cell line IPEC-J2-APN using flow cytometry (a+b) and on small intestinal epithelial
cells of porcine ileum (c). Detection of purified antibody was performed with FITC-conjugated anti-porcine IgA (a+c) or with FITC-conjugated anti-FedF (b). Nuclei
were counterstained with Hoechst. Scale bar = 100 µm.
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advanced selection techniques since the produced antibodies
are not similar.
Stable expression and binding of the target antigen was
confirmed for our chimeric antibody-antigen fusion protein,
indicating it is feasible to construct antibodies in this manner.
Only minimal degradation was observed after purification.
This chimeric mouse-porcine antibody will potentially
decrease porcine anti-mouse immune responses after immu-
nization as previously described.7 Some GFP impurities were
observed in the cell culture supernatant. We suspect these
GFP impurities are caused by dead cells due to loss of mem-
brane integrity, since GFP did not contain a secretion signal
in our vector. In our approach, no GFP impurities were
detected after porcine IgA-specific purification of the recom-
binant IgA antibodies. Therefore, a purification step, such as
size-exclusion chromatography or affinity chromatography,
should be added to obtain a highly pure product for use in
clinical applications.
In total, 122 GFP-expressing colonies were found after
single cell sorting of the GFPhigh population. Most of these
colonies showed a strong correlation between antibody pro-
duction and GFP expression after image analysis of the
formed monolayer patches. Some colonies with heterogenous
expression of GFP were detected. These showed no or very
low antibody production after further colony development.
Correlation of antibody production and GFP expression was
much higher when determining GFP expression using flow
cytometry, but was not necessary for determining best produ-
cer clones. Selection based on image analysis could already be
performed 5 days after single cell sorting, allowing faster
selection of high producer clones. Using automated image
analysis, work load can be significantly reduced since auto-
mated selection of high GFP expressing clones can be per-
formed for further expansion.30,31 Flow cytometric analysis
does require a sufficient number of cells, which extends the
time necessary to do the analysis. These cells can also not be
used for further colony development, increasing selection
time.
Our results indicate that the selection of GFPhigh-
expressing cells using FACS allows much faster selection of
strong antibody-producing CHO cells compared to standard
limited dilution techniques. In total, high-producing cells
could be selected in as little as 4 weeks. Compared to other
advanced screening techniques, high-producing clones could
be obtained in half the time. For this experiment, a broad
selection cutoff was made of the top 10% GFPhigh cells. More
stringent conditions, e.g., single cell sorting of top 1% GFPhigh
CHO cells, could be used to further improve the selection
process. Additionally, the use of multiple sequential selection
steps could be used to select for even higher antibody-
producing cells. This will, however, result in an increased
selection time, potentially doubling the selection process time.
In most systems, as well as in our own, the expression of
the selection marker is put under control of a separate pro-
motor. Generally, the SV40 promotor is chosen due to its high
stability and low propensity for gene silencing.32 Since placing
the selection marker under a separate, more stable promotor
than the gene of interest could be a disadvantage, it would be
interesting to put both genes under a single promotor.
A further improvement to our approach would be to con-
struct a quad-cistronic vector, in which the expression of the
genes encoding the selection marker, eGFP and the antibody
Figure 6. Antibody production workflow: from vector construction to antibody production and purification.
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heavy + light chains are all controlled by a single promoter.
Indeed, constructing both antibody chains and a selection
marker in a tri-cistronic vector under the control of a single
promotor improved the selection of stable high antibody-
producing cells.14 Moreover, the use of 2A peptide cleavage
allows the design and construction of quad-cistronic expres-
sion vectors.29 Further research is required to investigate
whether this type of system would be feasible. Combining
an IRES-based approach with 2A peptide cleavage could also
be very interesting if the use of quad-cistronic vectors proves
difficult. Since the selection marker is preferred to be
expressed in lower quantities, this can be placed behind an
IRES-sequence downstream of the 2A-construct.
In conclusion, our approach showed that it is feasible to
select stable transfected cells producing functional chimeric
antibody-antigen fusion proteins in a relative short timeframe.
In the future, this construct will be assessed for its effective-
ness as an oral vaccine strategy.
Material & methods
Vector construction
A sequence coding for a recombinant chimeric mouse-porcine
IgA-FedF fusion antibody, separated by furin + GT2A peptide
sequences was synthesized by Genscript and cloned into the
pcDNA3.1-N-eGFP vector at the KpnI restriction site, resulting
in a tri-cistronic vector encoding 3 separate polypeptides under
the control of a single CMV promotor. A (G4S)3-flexible linker
was placed between the heavy chain and the FedF antigen to
improve stability and reduce steric hindrance. A furin recogni-
tion site upstream of each GT2A sequence results in post-
translational cleavage of this fragment from the final protein
(Figure 1). The variable light and heavy chain sequences were
derived from an anti-pig APN hybridoma cell line (IMM013) as
described by Baert et al.6 The porcine constant light
(AAA03520.1) and IgA heavy (AAA65943.1) sequences were
derived from the GenBank genetic sequence database. For the
antigen, the 15th to 165th amino acid of the F18 fimbrial adhesin
FedF (4B4P) was used as previously described by Tiels et al.33
Cell lines
CHO-K1 cells were cultured in Ham’s F12 nutrient mixture
(Gibco), supplemented with 10% fetal calf serum (FCS,
Integro), 2 mM L-glutamine (Gibco), 100 U/ml penicillin,
100 µg/ml streptomycin (P/S) and 1 mM sodium pyruvate
(Gibco) at 37°C, 5% CO2. After transfection, 1 mg/ml
Geneticin® (G418, Life technologies) was added for initial
selection of stable transfectants. When stable clones were
obtained, the concentration of G418 was lowered to
0.15 mg/ml for maintenance and stability analysis. Cells
were subcultured every 3–4 days, when 100% confluency
was reached. The highest producing clone was adapted to
suspension culture growth as described by Costa et al.34 The
suspension medium (EX-CELL ACF CHO; Sigma) was sup-
plemented with 6 mM L-glutamine, 5% FCS, 1% P/S and
0.15 mg/ml G418. Suspension-adapted cells were seeded at
a density of 5.0 × 105 cells/ml and grown in 200 ml medium
in 500 ml shaker flasks at 37°C and 150 rpm without CO2.
When the maximal cell density was reached (3.0 × 106 cells/
ml), the cells were first expanded to 400 ml and then 2 L
medium in 1 and 5 L shaker flasks, respectively for recombi-
nant antibody production at a seeding density of 5.0 × 105
cells/ml. When the cells reached their maximal density
(3.0 × 106 cells/ml) in the 5 L shaker flasks, the temperature
was shifted to 30°C for optimal antibody production.10 The
cell culture supernatant was collected after 10 days when the
cell viability dropped below 90%.
A porcine intestinal epithelial cell line (IPEC-J2) was stably
transfected with pAPN.5 These cells were cultured in Dulbecco’s
modified Eagle’s (DMEM)/F12 (Gibco), supplemented with 10%
FCS, 1% recombinant human insulin, transferrin and sodium
selenite (ITS, Sigma), 5 ng/ml recombinant human epidermal
growth factor (Invitrogen), 4 mM L-glutamine (Gibco), P/S and
0.15 mg/ml G418 at 37°C and 5% CO2.
Stable transfection
Stable transfections of CHO cells with the expression plasmid
were performed using the jetPRIME transfection reagent
(polyplus) following the manufacturer’s instructions. The
cells (5.0 × 104) were seeded in a 24-well plate, grown to
60–80% confluence (1 day) and transfected with 0.5 µg plas-
mid DNA expressing eGFP and the recombinant antibody.
After 4 hours, medium was replaced with selective medium
(1 mg/ml G418). After 5 days, the cells were expanded to
6-well plates and further selected for 9 to 12 days before single
cell sorting.
Single cell sorting and selection of best producing clones
Nine or 12 days after stable transfection, single cell sorting
was performed using a FACSAria III cell sorter (BD
Biosciences). All transfected cells were detached using trypsin
buffer (0.25% trypsin + 1 mM EDTA) and resuspended in
PBS + 1% FCS. Propidium iodide (0.5 µg/ml; Sigma) was
added to stain dead cells. Doublets and dead cells were
excluded, and the 10% highest GFP expressing cells were
selected and single-cell sorted into five 96-well plates (460
wells in total). These cells were then further cultured until
colonies formed. Medium was replaced every 4 days. After
12 days, most colonies had grown to 100% confluence and
were expanded to 24-well plates at a concentration of
1.0 × 105 cells/well. Supernatant was subsequently collected
after 4 days to measure total antibody secretion. Cells were
collected, counted and analyzed using flow cytometry
(Cytoflex) and mean GFP expression was measured.
To match antibody production levels with GFP expression
levels, live cell imaging of transfected and sorted CHO cells
was performed with an Olympus IX81 inverted fluorescence
microscope (Olympus). Exposure time for eGFP was 200 ms
after excitation. Five days after transfection and 5 or 12 days
after sorting, both transmission and fluorescence images were
taken to observe colony formation and GFP fluorescence. The
fluorescent images of formed monolayer patches were pro-
cessed with ImageJ software to determine the mean fluores-
cence intensity (MFI) for each colony.
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Analysis of GFP expression stability
Stability of GFP expression was analyzed over time using flow
cytometry. Selected clones were maintained in culture for over
4 months. Cells were subcultured every 3–4 days, when 100%
confluency was reached. GFP expression was measured for
each selected clone at specific time-points. Dead cells were
excluded using Sytox blue staining (5 nM; Molecular probes).
A total of 10,000 viable, single cells were measured for each
clone (Cytoflex, Beckman Coulter). At specific time-points,
cell culture supernatant was collected, and recombinant IgA
antibody concentration was determined using an IgA-specific
sandwich ELISA. Selected clones retained their GFP expres-
sion and antibody production for a period of 4 months.
Sandwich ELISA
Polystyrene 96-well plates (Polysorb; Nunc-Immuno) were
coated with polyclonal anti-porcine IgA (H + L) (A100-102A;
Bethyl) in PBS (pH 7.4) at a concentration of 10 µg/ml. After
incubation at room temperature (RT) for 2 hours, the wells were
washed three times with PBST (PBS + 0.1% Tween-20), followed
by incubation with 250 µl blocking buffer (3% bovine serum
albumin (BSA) in PBST) overnight at 4°C. After washing 3 times
with PBST, 100 µl of supernatant (1/4 dilution) was added and
incubated for 2 hours at RT. Supernatant from non-transfected
CHO cells was added as negative control. A serial dilution of
porcine reference serum with known concentration of IgA
(RS10-107–4; Bethyl) was added to determine antibody concen-
trations. After incubation, wells were washed 3 times with PBST
and 100 µl polyclonal anti-pig IgA-HRP (A100-102P; Bethyl)
was added in PBST + 1% BSA (1:10,000 dilution) for 1 hour at
37°C. Wells were washed 3 times with PBST, after which 50 µl
ABTS (Roche) was added for 30 minutes at 37°C. The absor-
bance was measured at 405 nm with a Spectra Fluor microplate
reader (Tecan). Specific antibody productivity qab (pg/cell/day)
was calculated with the following formula:
qab ¼ ab
N
 ln
Cn
C0
 
Cn C0
where ab is the amount of produced antibody in pg, C0 and Cn
are the initial and final number of cells in each well and N was
the incubation time (days) until supernatant was collected.
Antibody purification
A mouse anti-porcine IgA antibody (in-house) was crosslinked
on a HiTrap Protein G column (GE Healthcare) using dimethyl
pimelimidate (Thermo Fisher). Non-crosslinked antibodies
were removed after washing with PBS and elution buffer (1 M
glycine, 3 M NaCl, pH 2.7). Next, supernatants containing the
recombinant antibody or porcine serum were run over the
column overnight at 4°C at a flow rate of 1 ml/min. After
a washing step to remove non-specific binding, elution buffer
was added, and the eluate was collected. After dialysis,
a bicinchoninic assay (BCA) was performed following the man-
ufacturer’s recommendations (Pierce BCA protein assay kit) to
determine eluted antibody concentration. Purity and stability of
purified antibody was subsequently tested.
SDS-PAGE and western blotting
The stability and purity of the purified recombinant antibody
was determined using Coomassie staining and western blot.
Purified antibody (2 µg) or pig serum IgA (2 µg) was mixed
with loading buffer (x5) containing β-mercaptoethanol
(Gibco), boiled for 10 minutes at 95°C and separated on
a 12% polyacrylamide gel at 120V in SDS-PAGE buffer for
2 hours using the Powerpac 300 system (Bio-rad). Coomassie
staining was performed with Coomassie staining solution (1 g
Coomassie Brilliant Blue (Bio-rad), 10% glacial acetic acid, 50%
methanol in ddH2O) and destained overnight (30% glacial
acetic acid, 10% methanol in ddH2O). Western blotting was
performed by transferring the antibodies to PVDF membranes
(Life technologies) using the PowerPac 300 system for 2 hours
at 80V. Membranes were blocked overnight at 4°C with 5%
skimmed milk in PBS with 0.2% Tween-80. IgA heavy chains
were detected with an HRP-conjugated anti-porcine IgA
(A100-102P, Bethyl). Washing between each step was done
with PBST (PBS + 0.1% Tween-20). Detection was performed
using pierce ECL western blotting substrate (Thermo Fisher)
and the chemidoc MP imaging system (Bio-rad).
FCM binding assay
For APN binding analysis, flow cytometry was performed
using the IPEC-J2-APN cell line. Cells were grown until
90% confluence and detached with StemPro accutase
(Gibco). Detached cells (3.0 × 105) were transferred to a con-
ical bottomed 96-well microtiter plate (Gibco) in 200 µl cul-
ture medium and centrifuged for 3 min at 350 g and 4°C. The
cells were incubated with 10 µg/ml purified recombinant
antibodies or medium containing 1% pig reference serum
(RS10-107–4, Bethyl) and incubated for 30 minutes on ice.
Staining of bound antibodies was performed with
a fluorescein isothiocyanate (FITC)-conjugated anti-porcine
IgA antibody (1:100 dilution) (A100-102F, Bethyl) (30 minutes
on ice). The antibody-linked FedF fragment was detected
using 50 µg/ml FITC-conjugated porcine anti-FedF polyclonal
antibody (in-house) (30 minutes on ice). Dead cells were
excluded using Sytox blue staining (5 nM; Molecular probes).
A total of 10,000 viable, single cells were measured for each
condition (Cytoflex, Beckman Coulter).
Immunohistochemistry
Cryosections of porcine ileum (3 week-old piglet) were made
and fixed for 10 minutes in acetone at −20°C. Next, the
cryosections (12 um) were washed with PBS and blocked
with 10% goat serum (diluted in PBS), followed by incubation
with 10 µg/ml APN-binding recombinant antibody or PBS
containing 1% pig reference serum for 1 hour at 37°C in
a humidified chamber. After washing with PBS, FITC-
conjugated anti-porcine IgA (1:100) was added for IgA detec-
tion. A nuclear counterstain with Hoechst (10 µg/ml) was
performed for 5 minutes. After additional washing, the slides
were mounted with DABCO. Images were acquired with
a fluorescent microscope (Leica).
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Statistical analysis
The correlation between the MFI of each colony and the
measured optical density (OD) values in the pig IgA ELISA
was determined by Pearson correlation using SPSS Statistics
25. P-values were calculated by two-tailed student’s t-test.
P < 0.05 was considered significant.
Abbreviations
APN Aminopeptidase N
BSA Bovine serum albumin
CHO Chinese hamster ovary
CMV Cytomegalovirus
E2A 2A peptide derived from equine rhinitis virus
EDTA Ethylenediaminetetraacetic acid
eGFP Enhanced GFP
ELISA Enzyme-linked immunosorbent assay
ETEC Enterotoxigenic Escherichia coli
F2A 2A peptide derived from foot-and-mouth disease virus
FACS Fluorescence-activated cell sorting
FCS Fetal calf serum
FedF Adhesin of F18+ ETEC
G418 Geneticin®
GFP Green fluorescent protein
GSG Glycine-Serine-Glycine amino acid sequence
GT2A T2A with a GSG linker
IgA Immunoglobulin A
IgG Immunoglobulin G
IPEC-J2 Intestinal porcine enterocyte cells isolated from the
jejunum
IPEC-J2-APN APN-expressing IPEC-J2 cell line
IRES Internal ribosome entry site
MFI Mean fluorescence intensity
P2A 2A peptide derived from porcine teschovirus-1
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel
electrophoresis
SIgA Secretory IgA
T2A 2A peptide derived from Thosea asigna virus
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